55 Results for "

Incontinence

" in MedChemExpress (MCE) Product Catalog:
Products (55)

55 Results for "Incontinence" in MCE Product Catalog:

28
28 Publications Verification
Cat. No.: HY-116771A
CAS No.: 138908-40-4
Purity:  99.98%
Target:  

Adrenergic Receptor

Research Areas:  

Metabolic Disease

CL316243 is a highly potent selective β3-adrenoceptor agonist with a EC50 of 3 nM, but is an extremely poor to β1/2- receptors .CL316243 is a effective stimulant of adipocyte lipolysis and increases brown adipose tissue thermogenesis and metabolic rate . CL316243 has the potential for the treatment obesity, diabetes and urge urinary incontinence .
loading...
    loading...
28
28 Publications Verification
Cat. No.: HY-116771
CAS No.: 183720-02-7
Purity:  99.37%
Target:  

Adrenergic Receptor

Research Areas:  

Metabolic Disease

CL316243 free acid is a highly potent selective β3-adrenoceptor agonist with a EC50 of 3 nM, but is an extremely poor to β1/2- receptors. CL316243 free acid is a effective stimulant of adipocyte lipolysis and increases brown adipose tissue thermogenesis and metabolic rate. CL316243 free acid has the potential for the treatment obesity, diabetes and urge urinary incontinence .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-A0033
CAS No.: 133099-04-4
Synonyms: UK-88525
Darifenacin (UK-88525) is a selective and orally active M3 muscarinic receptor (M3R) antagonist with a pKi of 8.9. Darifenacin binds >20-fold more specifically to M3R than to other muscarinic receptors. Darifenacin can be used in the study of urinary incontinence and other symptoms of overactive bladder. Darifenacin inhibits tumor growth in colorectal cancer cells and has anti-tumor effects .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-A0012
CAS No.: 133099-07-7
Synonyms: UK-88525 hydrobromide
Darifenacin (UK-88525) hydrobromide is a selective and orally active M3 muscarinic receptor (M3R) antagonist with a pKi of 8.9. Darifenacin hydrobromide binds >20-fold more specifically to M3R than to other muscarinic receptors. Darifenacin hydrobromide can be used in the study of urinary incontinence and other symptoms of overactive bladder. Darifenacin hydrobromide inhibits tumor growth in colorectal cancer cells and has anti-tumor effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19933
CAS No.: 1190389-15-1
Synonyms: MK-4618
Target:  

Adrenergic Receptor

Research Areas:  

Others

Vibegron (MK-4618) is a potent, highly selective and orally active β3-adrenoceptor agonist (EC50=1.1 nM). Vibegron can be used for severe urgency urinary incontinence related to overactive bladder .
loading...
    loading...
Cat. No.: HY-116408A
CAS No.: 54556-98-8
Purity:  99.89%
Target:  

mAChR Calcium Channel

Research Areas:  

Neurological Disease Cancer

Propiverine hydrochloride is a bladder spasmolytic with calcium antagonistic and anticholinergic properties. Propiverine hydrochloride can be used for the research of overactive blaqdder and urinary incontinence .
loading...
    loading...
Cat. No.: HY-117071
CAS No.: 219311-44-1
Purity:  98.72%
Synonyms: Ro 115-1240
Dabuzalgron (Ro 115-1240) is an orally active and selective α-1A adrenergic receptor agonist for the treatment of urinary incontinence. Dabuzalgron protects against Doxorubicin-induced cardiotoxicity by preserving mitochondrial function .
loading...
    loading...
Cat. No.: HY-154636
CAS No.: 8012-95-1
Research Areas:  

Endocrinology

Liquid Paraffin is a petroleum-derived mixture of saturated hydrocarbons and an orally active fecal lubricant. Liquid Paraffin is widely used in studies of constipation and fecal incontinence in children through its lubricating effect and the osmotic effect generated by its conversion to hydroxy fatty acids. Liquid Paraffin has high safety, is non-carcinogenic, and does not affect fat-soluble vitamin levels with long-term use. Liquid Paraffin does not cause abdominal pain or electrolyte disorders, but may lead to lipoid pneumonia and granulomas caused by rectal administration. Liquid Paraffin can also be used as a phase change material for thermal energy storage, or combined with nanoparticles to form a protective boundary film to reduce mechanical wear .
loading...
    loading...
Cat. No.: HY-B1711A
CAS No.: 4779-94-6
Target:  

Adrenergic Receptor

Research Areas:  

Endocrinology

Norfenefrine hydrochloride is an orally active, endogenously found α-adrenergic agonist and can be used for the research of female stress incontinence .
loading...
    loading...
Cat. No.: HY-116567
CAS No.: 192514-54-8
Purity:  99.77%
Target:  

Vasopressin Receptor

Research Areas:  

Metabolic Disease

OPC-51803 is an orally active nonpeptide vasopressin V2 receptor agonist. OPC-51803 can be used for the research of micturition disorders that result in frequent micturition, such as that from polyuria, nocturnal polyuria, and some kinds of urinary incontinence .
loading...
    loading...
Cat. No.: HY-B1711
CAS No.: 536-21-0
Target:  

Adrenergic Receptor

Research Areas:  

Endocrinology

Norfenefrine is an orally active, endogenously found α-adrenergic agonist and can be used for the research of female stress incontinence .
loading...
    loading...
Cat. No.: HY-W101935
CAS No.: 113712-06-4
Synonyms: N-Boc-D-arginine hydrochloride
Research Areas:  

Others

N-Boc-D-Arg hydrochloride (N-Boc-D-arginine hydrochloride) is an amino acid derivative with a Boc protecting group, which can be used to synthesize desmopressin with the effects of improving nocturia, urinary incontinence and enuresis .
loading...
    loading...
Cat. No.: HY-B0267C
CAS No.: 119618-21-2
Synonyms: Aroxybutynin
Target:  

mAChR

Research Areas:  

Neurological Disease

(R)-Oxybutynin (Aroxybutynin), an enantiomer of Oxybutynin, is an orally active muscarinic receptor antagonist. (R)-Oxybutynin exhibits antispasmodic and anticholinergic activities, and competitively antagonizes carbachol-induced contractions. (R)-Oxybutynin can be used in the research of urinary incontinence caused by neurogenic bladder dysfunction .
loading...
    loading...
Cat. No.: HY-14790
CAS No.: 98819-76-2
Synonyms: (S,S)-(+)-Reboxetine
Target:  

Monoamine Transporter

Esreboxetine ((S,S)-Reboxetine) is a selective norepinephrine transporter (NET) inhibitor, with a pIC50 of 9.6 and a pKi of 9.2 in rats, and it can cross the blood-brain barrier. Esreboxetine increases urethral closure pressure and urethral resistance in rats. Esreboxetine is applicable to research related to inflammatory pain and stress urinary incontinence .
loading...
    loading...
Cat. No.: HY-171048
CAS No.: 928122-40-1
Target:  

Androgen Receptor

Research Areas:  

Endocrinology Cancer

GTx-027 is an orally active and non-steroidal selective androgen receptor modulator (SARM). GTx-027 shows androgen receptor (AR) transactivation effects with the EC50 of 1.8 nM. GTx-027 acts selectively increase muscle weight (anabolic) without affecting secondary sexual organs (androgenic). GTx-027 has the protential for the study of breast cancer and stress urinary incontinence (SUI) .
loading...
    loading...
Cat. No.: HY-B0267B
CAS No.: 1207344-05-5
Synonyms: Aroxybutynin hydrochloride
Target:  

mAChR

Research Areas:  

Neurological Disease

(R)-Oxybutynin hydrochloride (Aroxybutynin hydrochloride), an enantiomer of Oxybutynin hydrochloride, is an orally active muscarinic receptor antagonist. (R)-Oxybutynin hydrochloride exhibits antispasmodic and anticholinergic activities, and competitively antagonizes carbachol-induced contractions. (R)-Oxybutynin hydrochloride can be used in the research of urinary incontinence caused by neurogenic bladder dysfunction .
loading...
    loading...
Cat. No.: HY-116567A
CAS No.: 192514-57-1
Purity:  99.94%
Target:  

Endogenous Metabolite

Research Areas:  

Endocrinology

(S)-OPC-51803 is an agonist of the vasopressin V2 receptor, with activity in suppressing nocturia and urinary incontinence. (S)-OPC-51803 was evaluated in terms of biological activity and showed a stronger V2 receptor agonist effect compared to its (R)-isomer. The use of (S)-OPC-51803 may improve the patient's ability to control nocturnal polyuria .
loading...
    loading...
Cat. No.: HY-W039283
CAS No.: 345-24-4
Target:  

MCHR1 (GPR24)

Research Areas:  

Neurological Disease Cancer

MCH-1 antagonist 2 (l-BROMO-2,4-DIFLUORO-5-NITROBEN-ZENE) is a melanin concentrating hormone-1 (MCH1) receptor-selective 4-aryl piperidine. MCH-1 antagonist 2 can be used for the research of depression, anxiety, obesity, urge incontinence, urinary incontinence, major depression, bipolar disorder, agoraphobia, specific phobia, social phobia, obsessive-compulsive disorder, post-traumatic stress disorder, acute stress disorder, urinary frequency, urinary urgency, nocturia, enuresis, bulimia, bulimia nervosa, anorexia nervosa, major depressive disorder, dysthymic disorder, bipolar 1 and 2 disorders, schizoaffective disorder, cognitive disorders with depressed mood, personality disorders, insomnia, hypersomnia, narcolepsy, circadian rhythm sleep disorder, nightmare disorder, sleep terror disorder, sleepwalking disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, overactive bladder .
loading...
    loading...
Cat. No.: HY-116408AS
Propiverine-d7 (hydrochloride) is the deuterium labeled Propiverine hydrochloride. Propiverine hydrochloride is a bladder spasmolytic with calcium antagonistic and anticholinergic properties. Propiverine hydrochloride can be used for the research of overactive blaqdder and urinary incontinence .
loading...
    loading...
Cat. No.: HY-U00357
CAS No.: 137315-05-0
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Urinary Incontinence-Targeting Compound 1 is a sulfonanilide derivative, used in the research of urinary incontinence.
loading...
    loading...